Kok DH - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Bone mineral density in developing children with osteogenesis imperfecta: a longitudinal study with 9 years of follow-up.

Kok DH, Sakkers RJ, Pruijs HE, Joosse P, Castelein RM. Kok DH, et al. Acta Orthop. 2013 Aug;84(4):431-6. doi: 10.3109/17453674.2013.831321. Acta Orthop. 2013. PMID: 23992144 Free PMC article.

Quality of life in children with osteogenesis imperfecta treated with oral bisphosphonates (Olpadronate): a 2-year randomized placebo-controlled trial.

Kok DH, Sakkers RJ, Janse AJ, Pruijs HE, Verbout AJ, Castelein RM, Engelbert RH. Kok DH, et al. Eur J Pediatr. 2007 Nov;166(11):1155-61. doi: 10.1007/s00431-006-0399-2. Epub 2007 Feb 17. Eur J Pediatr. 2007. PMID: 17308899 Clinical Trial.

Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study.

Sakkers R, Kok D, Engelbert R, van Dongen A, Jansen M, Pruijs H, Verbout A, Schweitzer D, Uiterwaal C. Sakkers R, et al. Lancet. 2004 May 1;363(9419):1427-31. doi: 10.1016/S0140-6736(04)16101-1. Lancet. 2004. PMID: 15121405 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters